The President of Venezuela, Nicolas Maduro, has said that he will give the COVAX system an ultimatum this week to send the country's share of COVID-19 vaccines as all pending payments had been made to COVAX, the global vaccine sharing facility, Reuters news agency reported on Monday.
COVAX reportedly informed Venezuela in June 2021 that the last four payments had been blocked by UBS. These payments cover the USD120m fees that have already been made.
Maduro was quoted as saying in a live appearance on state television that officials had been instructed to "give the COVAX system an ultimatum: they send us the vaccines or they give us the money back, period."
Venezuela is facing US sanctions that affect its access to the global financial system and reportedly relied on domestic banks to make part of the payment to the COVAX system with foreign currency.
The country has expressed interest in receiving the Johnson & Johnson (NYSE:JNJ) and Novavax (Nasdaq:NVAX) vaccines through COVAX.
Merck launches Phase 3 trial for dengue vaccine candidate V181
BioNet and Bio Farma sign MoU on TdaP vaccine
Dx&Vx accelerates universal COVID-19 vaccine development
Moderna withdraws application for flu-COVID combination vaccine pending additional efficacy data
CTP delivers 18,000 sqm Serbian facility for SCHOTT Pharma to support global expansion
LakeShore Biopharma launches novel packaging solution for YSJA rabies vaccine (Vero cell)
Scancell partners with NHS Cancer Vaccine Launch Pad to accelerate melanoma trial recruitment
Orexo reports positive results for powder-based intranasal vaccine using AmorphOX technology
GC Biopharma's BARYTHRAX receives Korean regulatory approval
GSK grants USD2m to boost adult vaccination efforts
Valneva and LimmaTech begin Phase 2 infant trial for Shigella vaccine candidate S4V2
Circio Holding and Entos Pharmaceuticals collaborate on circular RNA delivery
AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100